AAVogen

About:

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.

Top Investors: National Institutes of Health, Kilpatrick Townsend & Stockton LLP, Washington Research Foundation, National Cancer Institute SBIR Development Center, NIAMS

Description:

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases. This includes muscular dystrophy, inflammatory myopathies and cancer cachexia. We make you stronger.

Total Funding Amount:

$4.98M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2015-08-01

Contact Email:

danrodgers(AT)aavogen.com

Founders:

Buel Rodgers

Number of Employees:

1-10

Last Funding Date:

2023-08-01

IPO Status:

Private

Industries: